In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' [3]

Ehab Atallah, Hagop Kantarjian, Jorge Cortes

Research output: Contribution to journalLetter

Original languageEnglish (US)
Number of pages1
JournalNature Medicine
Volume13
Issue number1
DOIs
StatePublished - Jan 1 2007

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' [3]. / Atallah, Ehab; Kantarjian, Hagop; Cortes, Jorge.

In: Nature Medicine, Vol. 13, No. 1, 01.01.2007.

Research output: Contribution to journalLetter

@article{c8d05a0c55374a13b47fd4b99eb0d79d,
title = "In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' [3]",
author = "Ehab Atallah and Hagop Kantarjian and Jorge Cortes",
year = "2007",
month = "1",
day = "1",
doi = "10.1038/nm0107-14",
language = "English (US)",
volume = "13",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' [3]

AU - Atallah, Ehab

AU - Kantarjian, Hagop

AU - Cortes, Jorge

PY - 2007/1/1

Y1 - 2007/1/1

UR - http://www.scopus.com/inward/record.url?scp=33846086176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846086176&partnerID=8YFLogxK

U2 - 10.1038/nm0107-14

DO - 10.1038/nm0107-14

M3 - Letter

C2 - 17206119

AN - SCOPUS:33846086176

VL - 13

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 1

ER -